Correlation Between CP ALL and Mega Lifesciences

Can any of the company-specific risk be diversified away by investing in both CP ALL and Mega Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CP ALL and Mega Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CP ALL Public and Mega Lifesciences Public, you can compare the effects of market volatilities on CP ALL and Mega Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CP ALL with a short position of Mega Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CP ALL and Mega Lifesciences.

Diversification Opportunities for CP ALL and Mega Lifesciences

0.66

Correlation Coefficient

CP ALL  Mega Lifesciences

Poor diversification

The 3 months correlation between CPALL and Mega is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding CP ALL Public and Mega Lifesciences Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mega Lifesciences Public and CP ALL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CP ALL Public are associated (or correlated) with Mega Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mega Lifesciences Public has no effect on the direction of CP ALL i.e., CP ALL and Mega Lifesciences go up and down completely randomly.

Pair Corralation between CP ALL and Mega Lifesciences

Assuming the 90 days trading horizon CP ALL Public is expected to generate 0.67 times more return on investment than Mega Lifesciences. However, CP ALL Public is 1.48 times less risky than Mega Lifesciences. It trades about 0.01 of its potential returns per unit of risk. Mega Lifesciences Public is currently generating about -0.07 per unit of risk. If you would invest  6,350  in CP ALL Public on September 5, 2024 and sell it today you would earn a total of  25.00  from holding CP ALL Public or generate 0.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CP ALL Public  vs.  Mega Lifesciences Public

CP ALL Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CP ALL Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, CP ALL is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Mega Lifesciences Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mega Lifesciences Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with CP ALL and Mega Lifesciences

The main advantage of trading using opposite CP ALL and Mega Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CP ALL position performs unexpectedly, Mega Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mega Lifesciences will offset losses from the drop in Mega Lifesciences' long position.

The idea behind CP ALL Public and Mega Lifesciences Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.